TH1902

Theratechnologies · Phase 1 active Small molecule

At a glance

Generic name	TH1902
Also known as	TH1902 peptide-drug conjugate
Sponsor	Theratechnologies
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

TH1902 in Patients With Advanced Solid Tumors (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

TH1902 CI brief — competitive landscape report
TH1902 updates RSS · CI watch RSS
Theratechnologies portfolio CI